Surgery Partners Gross Margin 2013-2026 | SGRY
Current and historical gross margin for Surgery Partners (SGRY) over the last 10 years. The current gross profit margin for Surgery Partners as of June 30, 2026 is %.
| Surgery Partners Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2026-06-30 | $3.37B | $0.76B | 22.48% |
| 2026-03-31 | $3.34B | $0.76B | 22.82% |
| 2025-12-31 | $3.31B | $0.77B | 23.12% |
| 2025-09-30 | $3.29B | $0.79B | 23.94% |
| 2025-06-30 | $3.24B | $0.77B | 23.79% |
| 2025-03-31 | $3.17B | $0.75B | 23.74% |
| 2024-12-31 | $3.11B | $0.75B | 23.96% |
| 2024-09-30 | $2.98B | $0.71B | 23.66% |
| 2024-06-30 | $2.89B | $0.69B | 24.03% |
| 2024-03-31 | $2.79B | $0.67B | 23.94% |
| 2023-12-31 | $2.74B | $0.65B | 23.62% |
| 2023-09-30 | $2.72B | $0.64B | 23.50% |
| 2023-06-30 | $2.66B | $0.60B | 22.65% |
| 2023-03-31 | $2.61B | $0.58B | 22.38% |
| 2022-12-31 | $2.54B | $0.58B | 22.65% |
| 2022-09-30 | $2.44B | $0.54B | 22.03% |
| 2022-06-30 | $2.38B | $0.53B | 22.27% |
| 2022-03-31 | $2.31B | $0.51B | 22.23% |
| 2021-12-31 | $2.22B | $0.49B | 22.12% |
| 2021-09-30 | $2.16B | $0.48B | 22.20% |
| 2021-06-30 | $2.10B | $0.47B | 22.44% |
| 2021-03-31 | $1.93B | $0.41B | 21.13% |
| 2020-12-31 | $1.86B | $0.38B | 20.38% |
| 2020-09-30 | $1.83B | $0.37B | 20.39% |
| 2020-06-30 | $1.79B | $0.36B | 20.06% |
| 2020-03-31 | $1.86B | $0.41B | 21.99% |
| 2019-12-31 | $1.83B | $0.42B | 23.16% |
| 2019-09-30 | $1.81B | $0.43B | 23.60% |
| 2019-06-30 | $1.79B | $0.43B | 23.81% |
| 2019-03-31 | $1.78B | $0.42B | 23.47% |
| 2018-12-31 | $1.77B | $0.41B | 23.15% |
| 2018-09-30 | $1.74B | $0.40B | 23.05% |
| 2018-06-30 | $1.61B | $0.36B | 22.49% |
| 2018-03-31 | $1.47B | $0.34B | 23.07% |
| 2017-12-31 | $1.34B | $0.33B | 24.48% |
| 2017-09-30 | $1.19B | $0.30B | 25.13% |
| 2017-06-30 | $1.16B | $0.32B | 27.43% |
| 2017-03-31 | $1.17B | $0.33B | 28.15% |
| 2016-12-31 | $1.15B | $0.32B | 28.27% |
| 2016-09-30 | $1.10B | $0.31B | 28.29% |
| 2016-06-30 | $1.06B | $0.30B | 28.49% |
| 2016-03-31 | $1.00B | $0.29B | 29.11% |
| 2015-12-31 | $0.96B | $0.29B | 30.21% |
| 2015-06-30 | $0.53B | $0.17B | 31.89% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $1.838B | $3.309B |
| Surgery Partners, Inc. is a healthcare services company. The Company's outpatient delivery model focused on providing solutions for surgical and related ancillary care in support of its patients and physicians. Its operating segment consists of Surgical Facility Services segment, Ancillary Services segment and Optical Services segment. Surgery Partners, Inc. is based in Nashville, Tennessee. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $142.882B | 25.03 |
| CVS Health (CVS) | United States | $122.206B | 12.19 |
| HCA Healthcare (HCA) | United States | $92.119B | 14.32 |
| Elevance Health (ELV) | United States | $92.005B | 14.44 |
| Cencora (COR) | United States | $62.254B | 19.02 |
| Natera (NTRA) | United States | $49.267B | 0.00 |
| Labcorp Holdings (LH) | United States | $25.572B | 18.03 |
| Viatris (VTRS) | United States | $19.136B | 6.61 |
| Medpace Holdings (MEDP) | United States | $16.619B | 34.90 |
| DiDi Global (DIDIY) | China | $16.275B | 178.51 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $16.114B | 0.00 |
| Solventum (SOLV) | United States | $15.290B | 12.65 |
| Revvity (RVTY) | United States | $14.338B | 24.02 |
| Charles River Laboratories (CRL) | United States | $13.038B | 27.59 |
| ICON (ICLR) | Ireland | $12.935B | 17.58 |
| BrightSpring Health Services (BTSG) | United States | $11.931B | 41.02 |
| Avantor (AVTR) | United States | $10.254B | 18.49 |
| BioMerieux (BMXMF) | France | $10.192B | 0.00 |
| HealthEquity (HQY) | United States | $7.944B | 25.89 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.362B | 72.36 |
| PACS (PACS) | United States | $7.051B | 23.70 |
| Sonic Healthcare (SKHHY) | Australia | $6.687B | 0.00 |
| GETINGE (GNGBY) | Sweden | $6.654B | 18.79 |
| CochLear (CHEOY) | Australia | $6.355B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.282B | 23.76 |
| MiniMed (MMED) | United States | $6.181B | 0.00 |
| Sotera Health (SHC) | United States | $5.285B | 21.79 |
| Concentras Parent (CON) | United States | $4.566B | 22.52 |
| Organon (OGN) | United States | $3.585B | 4.55 |
| CareDx (CDNA) | United States | $2.709B | 308.06 |
| Alignment Healthcare (ALHC) | United States | $2.684B | 68.11 |
| GeneDx Holdings (WGS) | United States | $2.676B | 249.28 |
| Amplifon S.p.A (AMFPF) | Italy | $2.466B | 12.74 |
| Pediatrix Medical (MD) | United States | $2.187B | 12.81 |
| Establishment Labs Holdings (ESTA) | United States | $2.143B | 0.00 |
| Progyny (PGNY) | United States | $2.137B | 30.27 |
| COMPASS Pathways (CMPS) | United Kingdom | $2.013B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $1.914B | 0.00 |
| Bora Pharmaceuticals, - (BORAY) | Taiwan | $1.695B | 10.18 |
| Freenome (FRNM) | United States | $1.607B | 0.00 |
| Ardent Health (ARDT) | United States | $1.552B | 8.87 |
| Agilon Health (AGL) | United States | $1.551B | 0.00 |
| Nutex Health (NUTX) | United States | $1.486B | 8.52 |
| InnovAge Holding (INNV) | United States | $1.470B | 0.00 |
| Omada Health (OMDA) | United States | $1.255B | 256.25 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.241B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.220B | 23.73 |
| Teladoc Health (TDOC) | United States | $1.181B | 0.00 |
| CryoPort (CYRX) | United States | $0.808B | 0.00 |
| GMR Solutions (GMRS) | United States | $0.716B | 0.00 |
| Enhabit (EHAB) | United States | $0.709B | 25.89 |
| Forward Industries (FWDI) | United States | $0.513B | 0.00 |
| Oncology Institute (TOI) | United States | $0.507B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.504B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.474B | 0.00 |
| SBC Medicals (SBC) | United States | $0.467B | 9.66 |
| Shoulder Innovations (SI) | United States | $0.382B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.377B | 5.47 |
| Embecta (EMBC) | United States | $0.297B | 2.57 |
| Biodesix (BDSX) | United States | $0.289B | 0.00 |
| So-Young (SY) | China | $0.266B | 0.00 |
| LifeMD (LFMD) | United States | $0.166B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.109B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.101B | 0.00 |
| SkinHealth Systems (SKIN) | United States | $0.091B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.079B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.065B | 7.65 |
| Tevogen (TVGN) | United States | $0.049B | 0.00 |
| DocGo (DCGO) | United States | $0.037B | 0.00 |
| Lifeward (LFWD) | United States | $0.020B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.014B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.014B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.011B | 0.00 |
| Ainos (AIMD) | United States | $0.010B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.008B | 0.00 |
| Aclarion (ACON) | United States | $0.007B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.007B | 0.00 |
| 20/20 Biolabs (AIDX) | United States | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| Pomdoctor - (POM) | China | $0.005B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.004B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |